Actively Recruiting
Investigation of the Effect of Date Consumption on Hedonic Hunger and Appetite in Adult Individuals With Type 2 Diabetes
Led by Hacettepe University · Updated on 2025-02-13
64
Participants Needed
1
Research Sites
41 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study was to investigate the effects of date consumption on hedonic hunger and appetite hormones in individuals diagnosed with type 2 diabetes.The main questions it aims to answer are: * Does date consumption reduce hedonic hunger in individuals with type 2 diabetes? * Does persimmon consumption change Ghrelin, GLP-1 and GIP concentrations in individuals with Type 2 diabetes? * Does persimmon consumption reduce HOMA-IR and HbA1c values in individuals with Type 2 diabetes? * Does consumption of persimmon reduce LDL cholesterol, total cholesterol and triglyceride concentrations in individuals with type 2 diabetes? To see the effects of date consumption on hedonic hunger and appetite hormones, the researchers will compare individuals with type 2 diabetes who consume 3 dates daily with individuals with type 2 diabetes who do not. Participants: * Individuals in the intervention group will consume 3 (25 g) Baghdad dates (15 g CHO) daily as part of the breakfast meal, while individuals in the control group will not consume dates. * Three interviews will be conducted with patients. * A record of blood findings and questionnaires will be kept during these interviews.
CONDITIONS
Official Title
Investigation of the Effect of Date Consumption on Hedonic Hunger and Appetite in Adult Individuals With Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Type 2 diabetes aged 19 to 50 years (menopausal women excluded)
- Body mass index (BMI) between 25 and 35 kg/m2
- Nutritional Strength Scale score of 2.5 or higher
- Agree not to start new dietary supplements or alternative therapies during the study
- Agree to maintain current physical activity level and diet throughout the study
You will not qualify if you...
- Do not provide voluntary consent
- Nutritional Strength Scale score below 2.5
- Pregnant, breastfeeding, or planning pregnancy within 3 months
- Dietary energy intake less than 800 kcal/day or more than 4000 kcal/day
- Diagnosed with pre-diabetes, type 1 diabetes, or gestational diabetes
- Hemoglobin A1c (HbA1c) greater than 10
- Taking antibiotics or hormone replacement therapy
- History of cancer except non-melanoma skin cancer
- Regular date consumption before study start
- Using insulin or oral antidiabetic drugs containing thiazolidinedione
- History of diabetic ketoacidosis, coma, serious infections, surgery, trauma requiring insulin, dialysis, serious liver injury, or serious vascular complications requiring hospitalization within 6 months
- Taking medications affecting appetite such as psychotropics, antiepileptics, antidepressants, antipsychotics, or steroids
- Diagnosed with eating or psychological disorders
- Physical illnesses affecting appetite or eating behavior such as uncontrolled thyroid disorders, Cushing's disease, acromegaly, adrenal insufficiency, advanced chronic kidney failure, tuberculosis, or HIV infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Erzurum City Hospital
Erzurum, Palandöken, Turkey (Türkiye), 25070
Actively Recruiting
Research Team
A
AYŞE ÇAMLİ
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here